Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

453 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monovalent XBB.1.5 COVID-19 vaccine effectiveness against hospitalisations and deaths during the Omicron BA.2.86/JN.1 period among older adults in seven European countries: A VEBIS-EHR network study.
Nunes B, Humphreys J, Nicolay N, Braeye T, Van Evercooren I, Holm Hansen C, Moustsen-Helms IR, Sacco C, Fabiani M, Castilla J, Martínez-Baz I, Meijerink H, Machado A, Soares P, Ljung R, Pihlström N, Nardone A, Bacci S, Monge S; VEBIS-EHR working group. Nunes B, et al. Among authors: fabiani m. Expert Rev Vaccines. 2024 Jan-Dec;23(1):1085-1090. doi: 10.1080/14760584.2024.2428800. Epub 2024 Nov 25. Expert Rev Vaccines. 2024. PMID: 39535047 Free article.
Estimating averted COVID-19 cases, hospitalisations, intensive care unit admissions and deaths by COVID-19 vaccination, Italy, January-September 2021.
Sacco C, Mateo-Urdiales A, Petrone D, Spuri M, Fabiani M, Vescio MF, Bressi M, Riccardo F, Del Manso M, Bella A, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group. Sacco C, et al. Among authors: fabiani m. Euro Surveill. 2021 Nov;26(47):2101001. doi: 10.2807/1560-7917.ES.2021.26.47.2101001. Euro Surveill. 2021. PMID: 34823637 Free PMC article.
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021.
Fabiani M, Puopolo M, Filia A, Sacco C, Mateo-Urdiales A, Spila Alegiani S, Del Manso M, D'Ancona F, Vescio F, Bressi M, Petrone D, Spuri M, Rota MC, Massari M, Da Cas R, Morciano C, Stefanelli P, Bella A, Tallon M, Proietti V, Siddu A, Battilomo S, Palamara AT, Popoli P, Brusaferro S, Rezza G, Riccardo F, Menniti Ippolito F, Pezzotti P. Fabiani M, et al. Expert Rev Vaccines. 2022 Jul;21(7):975-982. doi: 10.1080/14760584.2022.2064280. Epub 2022 Apr 15. Expert Rev Vaccines. 2022. PMID: 35389748 Free PMC article.
COVID-19 vaccines coverage and effectiveness against SARS-CoV-2 infection among residents in the largest Health Authority of Lazio region (Italy): a population-based cohort study.
Fano V, Coviello E, Consonni D, Agresta A, Orsini N, Crielesi A, Miglietta AS, Pasqua C, Vairo F, Vivaldi F, De Angelis G, Colaiocco G, Fabiani M. Fano V, et al. Among authors: fabiani m. Expert Rev Vaccines. 2022 Aug;21(8):1147-1157. doi: 10.1080/14760584.2022.2080057. Epub 2022 Jun 1. Expert Rev Vaccines. 2022. PMID: 35584901 Free article.
Risk and protective factors for SARS-CoV-2 reinfections, surveillance data, Italy, August 2021 to March 2022.
Sacco C, Petrone D, Del Manso M, Mateo-Urdiales A, Fabiani M, Bressi M, Bella A, Pezzotti P, Rota MC, Riccardo F; Italian Integrated Surveillance of COVID-19 study group. Sacco C, et al. Among authors: fabiani m. Euro Surveill. 2022 May;27(20):2200372. doi: 10.2807/1560-7917.ES.2022.27.20.2200372. Euro Surveill. 2022. PMID: 35593164 Free PMC article.
Reduction of the risk of severe COVID-19 due to Omicron compared to Delta variant in Italy (November 2021 - February 2022).
Petrone D, Mateo-Urdiales A, Sacco C, Riccardo F, Bella A, Ambrosio L, Lo Presti A, Di Martino A, Ceccarelli E, Del Manso M, Fabiani M, Stefanelli P, Pezzotti P, Palamara A; Italian Integrated Surveillance of COVID-19. Petrone D, et al. Among authors: fabiani m. Int J Infect Dis. 2023 Apr;129:135-141. doi: 10.1016/j.ijid.2023.01.027. Epub 2023 Jan 26. Int J Infect Dis. 2023. PMID: 36708869 Free PMC article.
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study.
Mateo-Urdiales A, Sacco C, Fotakis EA, Del Manso M, Bella A, Riccardo F, Bressi M, Rota MC, Petrone D, Siddu A, Fedele G, Stefanelli P, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M. Mateo-Urdiales A, et al. Among authors: fabiani m. Lancet Infect Dis. 2023 Dec;23(12):1349-1359. doi: 10.1016/S1473-3099(23)00374-2. Epub 2023 Jul 18. Lancet Infect Dis. 2023. PMID: 37478877
Estimated Effectiveness of a Primary Cycle of Protein Recombinant Vaccine NVX-CoV2373 Against COVID-19.
Mateo-Urdiales A, Sacco C, Petrone D, Bella A, Riccardo F, Del Manso M, Bressi M, Siddu A, Brusaferro S, Palamara AT, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. Among authors: fabiani m. JAMA Netw Open. 2023 Oct 2;6(10):e2336854. doi: 10.1001/jamanetworkopen.2023.36854. JAMA Netw Open. 2023. PMID: 37792377 Free PMC article.
453 results